Bristol Myers Squibb (BMY) Earnings Call Transcripts

25 earnings calls on file for Bristol Myers Squibb, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.

Latest earnings call

Bristol Myers Squibb Q3 2026 Earnings Call

Oct 29, 2026 9,976 words · 43 min read

Christopher S. BoernerBoard Chair and Chief Executive Officer
David V. ElkinsChief Financial Officer
Adam LenkowskyChief Commercialization
Cristian MassacesiChief Medical Officer and Head of Global Drug Development

Prepared remarks and the full analyst Q&A, speaker by speaker.

Earnings calls

Calls25

LatestOct 29, 2026

SinceQ4 2019

All 25 Bristol Myers Squibb transcripts Register to get access to Bristol Myers Squibb’s earnings call transcripts.